Plan B One-Step Goes OTC, With Three-Year Exclusivity, Lower Age Limit
This article was originally published in The Tan Sheet
Executive Summary
FDA approved Plan B One-Step to be sold in some OTC venues to women 15 and older, lowering the age restriction and moving the product out from behind pharmacy counters. Teva Women’s Health gets three years of exclusivity for the product, based on studies of label comprehension among women as young as 15.
You may also be interested in...
Teva Plan B OTC Application Fails Political Test After Clearing FDA Hurdle
HHS Secretary Sebelius says Teva must show more evidence of how young adolescent females would use Plan B One-Step as an OTC. But obtaining such clinical data for the emergency contraceptive – in excess of what FDA already needed to approve it – appears nearly impossible, experts say.
OTC Decisions November-December: GSK Labels For Nexium Promotion, Voltaren 2-Pack Approved
Approvals by FDA also include revised container and consumer information labeling for J&J's Men’s Rogaine to align with labeling for Women’s Rogaine; bonus-pack labeling for Bayer AG’s Aleve; and
J&J CEO: COVID-19 ‘Demonstrated Importance of Self-Care Overall’
During JP Morgan conference, Alex Gorsky suggests responding to pandemic is changing health care, including businesses providing pharmaceuticals, medical technologies, nutritionals and other necessary products.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: